Trials / Completed
CompletedNCT03315403
Quantitative Polymerase Chain Reaction for Improved Detection of Pneumococci in CAP "CAPTAIN"
Community-Acquired Pneumonia: lytA TArgeted Real Time Quantitative Polymerase chaIN Reaction for Improved Detection of Pneumococci (CAPTAIN)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 922 (actual)
- Sponsor
- Medical Center Alkmaar · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the added diagnostic value of a quantitative polymerase chain reaction targeting the lytA gene in detecting pneumococci in patients with community-acquired pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | LytA targeted quantitative polymerase chain reaction (qPCR) | LytA qPCR and cultures will be performed on samples of the upper respiratory tract (nasopahrynx, oropharynx, saliva, sputum if available) |
Timeline
- Start date
- 2018-04-05
- Primary completion
- 2020-03-12
- Completion
- 2020-03-12
- First posted
- 2017-10-20
- Last updated
- 2022-04-08
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03315403. Inclusion in this directory is not an endorsement.